Kim Branson

Kim Branson, SVP and Global Head of AI and Machine Learning for GSK, discusses how AI has revolutionized drug discovery and development, highlighting its applications in the lab. They also delve into the criteria for an ideal biopharma partner and the allure of innovative solutions in the biotech AI space.

Kim Branson, Senior VP and Global Head of AI and Machine Learning at GSK, shares her fascinating career journey from structural biology to leading AI initiatives. She delves into how GSK is utilizing machine learning to enhance drug development, focusing on precision medicine in oncology. Kim discusses the importance of combining ML experts with domain specialists and treating data as a strategic asset. She also highlights the future of multimodal datasets from wearables and the significance of responsible AI governance in pharmaceutical innovation.

Kim Branson, SVP and global head of AI and machine learning at GSK, shares insights on leveraging machine learning in pharmaceuticals. He discusses the integration of genetics data for drug discovery and the impressive 500 billion node knowledge graph designed to mine scientific literature. Kim also highlights their recent collaboration with King’s College, focusing on personalized cancer research using AI. The conversation dives into the challenges of building scalable AI infrastructures and the critical need for robust evaluation programs in real-world applications.